Embla Medical hf
CSE:EMBLA

Watchlist Manager
Embla Medical hf Logo
Embla Medical hf
CSE:EMBLA
Watchlist
Price: 35.3 DKK 2.32% Market Closed
Market Cap: 15.1B DKK
Have any thoughts about
Embla Medical hf?
Write Note

Embla Medical hf
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Embla Medical hf
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Embla Medical hf
CSE:EMBLA
Accrued Liabilities
$46.7m
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
3%
O
Ossur hf
CSE:OSSR
Accrued Liabilities
$43.2m
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
2%
No Stocks Found

Embla Medical hf
Glance View

Market Cap
15.1B DKK
Industry
Health Care

Embla Medical hf, a rising star in the medical device industry, has carved a niche in the sleep diagnostics sector with its innovative technology. Founded with the vision of transforming sleep health, the Iceland-based company specializes in developing advanced sleep diagnostic systems. These devices are crucial in identifying sleep disorders, a growing concern globally as awareness about sleep health continues to rise. Embla Medical’s flagship products are portable and user-friendly diagnostic tools that allow both clinicians and patients to monitor sleep patterns in real-time. By focusing on cutting-edge technology and accuracy, the company has established itself as a trusted partner in medical facilities worldwide, enhancing its reputation and solidifying its market presence. The business model of Embla Medical relies heavily on the research and development of its diagnostic systems, complemented by a strategic emphasis on customer service and support. The revenue stream is generated through the sale of these sophisticated devices to hospitals, sleep clinics, and directly to healthcare providers. Additionally, they offer ongoing maintenance services and software updates, providing a continuous source of income post-sale. By integrating software with hardware, they ensure that their equipment remains at the forefront of technological advancements in sleep diagnostics. This not only drives sales but also builds a loyal customer base that places high value on efficacy and ease of use. Embla Medical's focus on innovation and customer satisfaction positions them well to capitalize on the growing market for sleep healthcare solutions.

EMBLA Intrinsic Value
38.64 DKK
Undervaluation 9%
Intrinsic Value
Price

See Also

What is Embla Medical hf's Accrued Liabilities?
Accrued Liabilities
46.7m USD

Based on the financial report for Sep 30, 2024, Embla Medical hf's Accrued Liabilities amounts to 46.7m USD.

What is Embla Medical hf's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
3%

Over the last year, the Accrued Liabilities growth was 6%. The average annual Accrued Liabilities growth rates for Embla Medical hf have been 6% over the past three years , 4% over the past five years , and 3% over the past ten years .

Back to Top